OSX 4.92% 6.4¢ osteopore limited

Ann: Prospectus for Renounceable Rights Issue, page-15

  1. 1,582 Posts.
    lightbulb Created with Sketch. 386
    The commercialisation strategy does not add up. Year on year has seen no growth despite an acquisition?

    Since the initial board from the successful IPO days resigned and new management took over it has been going downhill ever since. Other than getting themselves set with performance shares and increasing remuneration, what have they really achieved so far? The consolidation did not make sense as they did not have billions of shares on issue to begin with. Now this 94% discount post consolidation and options that is way in the money already? None of this makes sense and it spells out just how loose or inexperienced the board is for signing all of this off.

    All IMO, DYOR

 
watchlist Created with Sketch. Add OSX (ASX) to my watchlist
(20min delay)
Last
6.4¢
Change
0.003(4.92%)
Mkt cap ! $7.319M
Open High Low Value Volume
6.0¢ 6.6¢ 5.9¢ $173.8K 2.783M

Buyers (Bids)

No. Vol. Price($)
1 373082 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 9999 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
6.3¢
  Change
0.003 ( 5.53 %)
Open High Low Volume
6.0¢ 6.6¢ 5.9¢ 550208
Last updated 15.57pm 14/06/2024 ?
OSX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.